*Benjamin Hoehn1, Zhahirul Islam2, Kazim A. Sheikh3, Thomas Harbo4, Israt Jahan2, Shoma Hayat2, Henk-André Kroon1, Ellen Cahir-McFarland1, Ted Yednock1, Sanjay Keswani1, Quazi Deen Mohammad5
(1. Annexon Biosciences, Inc., Brisbane, CA, USA, 2. Laboratory of Gut-Brain Signaling, Laboratory Sciences and Services Division, icddr,b, Dhaka, Bangladesh, 3. Department of Neurology, McGovern Medical School, Houston, TX, USA, 4. Department of Neurology, Aarhus University Hospital, Aarhus, Denmark, 5. National Institute of Neurosciences and Hospital, Dhaka, Bangladesh)
キーワード:Guillain-Barré syndrome, neurofilament-light, prognostic biomarker, complement
抄録パスワード認証
抄録本文の閲覧にはパスワードが必要です。以下のパスワードをご入力の上、ご利用ください。
PW: Neuro2022